Scarica l'app Stockscreener
130.68
4.47%
-6.04
Dopo l'orario di chiusura:
130.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ICUI Giù?
Forum
Previsione
Frazionamento azionario
Icu Medical Inc Borsa (ICUI) Ultime notizie
Central Venous Catheter Market Outlook 2025-2032: Trends, - openPR.com
KeyBanc cuts ICU Medical stock target to $191, keeps Overweight By Investing.com - Investing.com Canada
KeyBanc Adjusts ICU Medical (ICUI) Price Target Amid Economic Concerns | ICUI Stock News - GuruFocus
Midday Stock Roundup: Markets Drop around 3% Across the Board - Orange County Business Journal
Peripheral Intravenous Catheters Market Is Booming Worldwide 2025-2032 | BD, ICU Medical, Inc., Surmodics, Inc. - openPR.com
Insiders At ICU Medical Sold US$2.3m In Stock, Alluding To Potential Weakness - simplywall.st
Programmable Infusion Pumps And Catheters Market Set to Witness - openPR.com
ICU stock hits 52-week low at $1.5 amid market challenges - MSN
Needham & Company LLC Reiterates "Hold" Rating for ICU Medical (NASDAQ:ICUI) - MarketBeat
Commit To Buy ICU Medical At $110, Earn 14.8% Annualized Using Options - Nasdaq
U.S. Intravenous Solutions Market Deep Research Report with Forecast to 2032 | Baxter International Inc., ICU Medical - openPR.com
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts - MSN
How ICU Medical plans to mitigate tariff impact - MassDevice
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps - MSN
ICU Medical Rolls Out New Category of Infusion Pumps - Medical Product Outsourcing
ICU Medical at 24th Annual Needham: Strategic Moves Amid Tariff Challenges - Investing.com Canada
ICU Medical launches new category of infusion pumps - MassDevice
Intravenous Solutions Market Is Booming Worldwide | Baxter - openPR.com
ICU Medical Receives FDA Clearances for Plum Solo IV Pump, Updated Plum Duo Software - MarketScreener
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps - BioSpace
- ICU Medical Introduces Its New Category of Infusion Devices - TradingView
ICU Medical : Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps - MarketScreener
Cinctive Capital Management LP Boosts Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI) - MarketBeat
ICU Medical Inc (ICUI) Trading 4.37% Higher on Apr 2 - GuruFocus
ICU Medical : Infusion Assessment Program Earns INS Seal of Approval - MarketScreener
When the Price of (ICUI) Talks, People Listen - news.stocktradersdaily.com
Syringe Market Is Booming Worldwide 2025-2032 | ICU Medical, - openPR.com
Intravenous Sets Market Growth in Future Scope 2025-2032 | B. Braun, Baxter, ICU Medical, Shandong Weigao - openPR.com
Europe Infusion Therapy Market: Growth, Trends & Forecast - openPR.com
Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch - Yahoo Finance
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
ICU Medical Leadership Takes Center Stage at Major Healthcare Conference: Key Updates Coming - Stock Titan
Raymond James upgrades ICU Medical to Buy despite risks - MSN
Smiths Medical recalls port implants, warns on endotracheal tubes - MedTech Dive
Programmable Infusion Pumps And Catheters Market Future - openPR
Infusion Therapy Market in the Spotlight: New Technologies - openPR.com
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business - Simply Wall St
ICU Medical at KeyBanc Forum: Strategic Moves Amid Challenges By Investing.com - Investing.com Canada
ICU Medical Says Higher Tariffs ‘Could be Material’ - Orange County Business Journal
ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by Raymond James - Defense World
Raymond James upgrades ICU Medical to Buy despite risks (ICUI:NASDAQ) - Seeking Alpha
US Bancorp DE Raises Position in ICU Medical, Inc. (NASDAQ:ICUI) - Defense World
Raymond James Upgrades ICU Medical to Strong Buy From Outperform, Adjusts Price Target to $197 From $205 - Marketscreener.com
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):